Offline mode

Intrinsic Factor Ab ELISA

Buy on the e-shop
Catalog no.RE70881
Regulatory Status
EU: CE
Kit size
12 x 8
Method
ELISA
Incubation time
1 x 30 min, 2 x 15 min
Standard range
0 - 300 U/mL, cut-off 15 U/mL
Specimen / Volumes
10 µL serum
Substrate / isotope
TMB 450 nm
instructions for usecertificateMSDS

Intrinsic factor is a solid phase enzyme immunoassay with recombinant human intrinsic factor for the quantitative detection of IgG antibodies against intrinsic factor. The assay is a tool in the diagnosis of pernicious anaemia (Biermer`s anaemia) Pernicious anaemia is the end stage of an autoimmune gastritis (type A gastritis) resulting in destruction of the gastric mucosa. A small proportion (10-15%) of patients with autoimmune gastritis develop pernicious anaemia. Pernicious anaemia is the most common cause of vitamin B12 deficiency in Western populations. It is caused by a lack of intrinsic factor, a glycoprotein needed to absorb vitamin B12 from the gastrointestinal tract. Intrinsic factor is produced by gastric parietal cells. Vitamin B12, in turn, is necessary for the formation of red blood cells. Pernicious anaemia usually does not appear before the age of 30. The average age at diagnosis is 60 years. In fact, one recent study revealed that nearly 2 percent of individuals over 60 years old suffer from pernicious anaemia. Furthermore, slightly more women than men are affected. The disease can affect all ethnic groups, but occurs more often among people of Scandinavian or Northern European descent. Autoantibodies in pernicious anaemia target parietal cells and intrinsic factor. Antibodies against parietal cells are 80-90% sensitive but can be detected also in up to 5% of the healthy population. Antibodies against intrinsic factor show a sensitivity of 50-70% with a specificity of 100% in a population of healthy blood donors.

For concrete data please consult the Instruction for Use in the download box on the top right side.

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.